Kiniksa Pharmaceuticals International (KNSA) Share-based Compensation (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) recorded Share-based Compensation of $11.64 million in Q2 2026, up 31.1% from $8.88 million a year earlier and up 15.7% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Share-based Compensation (2017 - 2026) Analysis & Trends
On a TTM basis, Kiniksa Pharmaceuticals International's Share-based Compensation came in at $42.07 million as of Jun 30, 2026, up 28.5% year-over-year; for FY2025, it came in at $37 million, up 20.6% from FY2024.
- Annual Share-based Compensation has increased for three straight years, with a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $30.69 million in FY2024 (+13.1%), $27.15 million in FY2023 (+8.1%), $25.12 million in FY2022 (-0.2%) and $25.17 million in FY2021 (+20.6%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q3 2017.
- On a year-over-year basis, Share-based Compensation has increased for 12 consecutive quarters, with growth averaging 20.5% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 31.1% in Q2 2026, against a decline of 15.4% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.06 million (Q1 2026), $10.24 million (Q4 2025) and $10.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 11.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.64 Mn |
| Mar 31, 2026 | 10.06 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 10.14 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 7.83 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Sep 30, 2023 | 6.79 Mn |
| Jun 30, 2023 | 6.47 Mn |
| Mar 31, 2023 | 6.12 Mn |
| Dec 31, 2022 | 6.37 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.68 Mn |
| Mar 31, 2022 | 6.03 Mn |
| Dec 31, 2021 | 6.13 Mn |
| Sep 30, 2021 | 6.20 Mn |
API Access
Kiniksa Pharmaceuticals International Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();